Reading the tape
NASDAQ: NOTV
Inotiv, Inc.
Healthcare · Medical - Diagnostics & Research
Market Cap
$10.39M
52w High
$3.32
52w Low
$0.22
P/E
-0.15
Volume
1.00M
Outstanding Shares
34.40M
Price vs Fundamentals
Why The Stock Is Moving
Likely multiple compressionModerate confidence
Note: The most recent financial data is over 3 months old. Metrics shown may not reflect the latest reporting period.
1Y Price: -85.19%Revenue (TTM): 8.19%FCF (TTM): -10.68%
What changed
The stock fell 85.19% over the last year. Revenue grew 8.19% over the trailing twelve months. Operating margin moved from -18.91% to -6.17%. Free cash flow declined 10.68% over the trailing twelve months.
What the market seems to be pricing
Visible fundamentals weakened far less than the stock price. The market appears to be discounting durability, risk, or trust rather than just the latest reported numbers.
What would invalidate this read
This read changes if operating margin (currently -6.17%) continues to decline, or if revenue growth turns negative. The bull case requires the business to hold its current trajectory.
Company profile
Inotiv, Inc. provides drug discovery and development services to the pharmaceutical, chemical, and medical device industries; and sells analytical instruments to the pharmaceutical development and contract research industries.
CEORobert W. Leasure Jr.
SectorHealthcare
IndustryMedical - Diagnostics & Research
Employees1,977
IPO dateNov 25, 1997
Valuation
Forward P/E—
EV/EBITDA21.37
Enterprise value$528.95M
Stock splits
No stock splits recorded for this ticker.
Profitability & growth
Revenue growth0.84%
Gross margin18.1%▼44.03%vs FY2024
Operating margin-6.17%▲65.79%vs FY2024
ROE-50.45%▲20.68%vs FY2024
Analyst consensus
RatingBuy
Target price$3.00▲892.72%
2
Buy
1
Hold
0
Sell
Analyst ratings tend to be lagging indicators. Use as one signal among many.
Earnings
Full quarter-by-quarter history of actuals vs estimates. Switch into compare mode to inspect one metric year-over-year.
Next report
May 6, 2026
Q2 FY26 · EPS est -$0.64 · Revenue est $124.74M
View